Evaluating Diffuse Liver Disease

Room A 101-102      16:00 - 18:00                  Chairs: Masayuki Kanematsu and Charles A. McKenzie

16:00      332.    Liver Texture Analysis: Robustness of Measurement in Cirrhotic Patients and Healthy Volunteers - not available

Kieren G. Hollingsworth1, David J. Lomas1

1University of Cambridge, Cambridge, UK

16:12      333.    Characterization of Liver Cirrhosis with a Dual-Input Perfusion Model - not available

Henry Rusinek1, Myra Finn1, Pari A. Pandharipande1, Glenn A. Krinsky1, Vivian S. Lee1, Mari Hagiwara1,

Bachir Taouli1

1NYU School of Medicine, New York, New York, USA

16:24      334.    A Quantity Analysis of Hepatic Perfusion in Patients with Liver Cirrhosis Before Liver Transplantation: By Using Dynamic MR Imaging

Hao Zhang1, Jingtao Miao1, Aihua Gu1, Xueqian Xie1, Zhiyan He1, Tiening Zhang1, Yunsheng Hu1

1Shanghai Jiaotong University Affiliated First People Hospital, Shanghai, People's Republic of China

16:36      335.    MR Assessment of the Effect of a Low Carbohydrate Diet on Hepatic Fat Content - not available

Kieren G. Hollingsworth1, Ziyad Abubacker1, Ilse Joubert2, Michael Allison1, David J. Lomas1

1University of Cambridge, Cambridge, UK; 2Addenbrookes Hospital, Cambridge, UK

16:48      336.    MR Spectroscopy of Non-Alcoholic Fatty Liver Disease

Susan Moyher Noworolski1, Phyllis Tien1, Antonio Westphalen1, Raphael Merriman1, Daniel B. Vigneron1,

Aliya Qayyum1

1The University of California, San Francisco, San Francisco, California, USA

17:00      337.    Towards Noninvasive Biomarkers of Non-Alcoholic Steatohepatitis

Ian R. Corbin1, Emma Furth1, Stephen Pickup1, Edward J. Delikatny1

1University of Pennsylvania, Philadelphia, Pennsylvania, USA

17:12      338.    Dual-Echo In- And Opposed-Phase MRI for the Quantification of Hepatic Steatosis on Phantoms with MR Spectroscopy to Resolve Ambiguity of Fat or Water Dominance - not available

Jerry S. Chang1, Bachir Taouli2, Nouha Salibi3, Vivian S. Lee2

1New Rochelle Radiology Associates, New Rochelle, New York, USA; 2NYU Medical Center, New York, New York, USA; 3Siemens Medical Solutions USA,Inc., St. Louis, Missouri, USA

17:24      339.    In Vivo MR-Elastography of Liver Fibrosis

Frank Peeters1, Ralph Sinkus2, Najat Salameh1, Laurence Annet1, Leon C. ter Beek3, Bernard E. Van Beers1

1St-Luc University Hospital, UCL, Brussels, Belgium; 2ESPCI, Paris, France; 3Philips Medical Systems, Brussels, Belgium

17:36      340.    In Vivo MR Elastography of the Liver: Preliminary Results

Olivier Rouviere1, Meng Yin1, M Alex Dresner2, Phillip J. Rossman1, Lawrence J. Burgart1, Jeff L. Fidler1,

Richard L. Ehman1

1Mayo Clinic, Rochester, Minnesota, USA; 2Hammersmith Hospital, London, UK

17:48      341.    Relationship Between Microvessel Density(MVD) of Malignant and Benign Hepatic Lesions and Dynamic Enhanced MRI  - not available

Jian Wang1

1Changhai Hospital, Shanghai, People's Republic of China